Alison Bauer, University of Colorado Anschutz Medical Campus (IMAGE)
Caption
This is Alison Bauer, PhD, and colleagues identify MUC5AC as a new target in KRAS-driven lung cancer.
Credit
University of Colorado Cancer Center
Usage Restrictions
None
License
Licensed content